Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 24, 2010. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility (PDMRs) regarding the vesting of 2007 Performance Share Plan (PSP) awards. The three-year performance period for these awards concluded on December 31, 2009.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of executive compensation vesting events rather than a financial results report.
Material Changes and Compensation Outcomes
The Remuneration Committee determined the vesting outcomes based on Total Shareholder Return (TSR) and Earnings Per Share (EPS) performance:
- Executive Directors and CET Members (2007 Awards): Awards were dependent on TSR performance. GSK ranked at the median of the comparator group, resulting in 35% of the awards vesting.
- Senior Executives (Appointed to CET post-2007): Awards were split between TSR and EPS measures. Half of these awards lapsed because EPS performance conditions were not met. Of the remaining half subject to TSR, 35% vested.
Specific vesting details for Executive Directors (denoted with *) and other CET members include:
| Name | Role | Shares/ADSs Vested |
|---|---|---|
| Mr A Witty | Executive Director | 29,750 |
| Mr J S Heslop | Executive Director | 36,750 |
| Mr M Slaoui | Executive Director | 24,150 |
| Mr J M Clarke | CET Member | 26,950 |
| Mr M Dunoyer | CET Member | 10,150 |
| Mr D Learmouth | CET Member | 7,438 |
| Mr W C Louv | CET Member | 8,750 |
| Mr D J Phelan | CET Member | 13,475 |
| Mr D Pulman | CET Member | 8,750 |
For senior executives with split criteria (TSR/EPS), the following shares vested under the TSR measure (35% of the TSR portion), while the EPS portion lapsed:
| Name | Shares Vested (TSR Portion) |
|---|---|
| Mr S M Bicknell | 1,554 |
| Mr E J Gray | 2,065 |
| Mr D S Redfern | 2,065 |
| Mr J R Stephenne | 4,655 |
| Ms C Thomas | 1,554 |
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on future operations, or specific risk factors. The document strictly addresses the notification of transactions under Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Verify the specific TSR comparator group used to determine the median ranking for the 2007 PSP awards.
- Confirm the exact EPS targets that were not met, leading to the lapse of 50% of awards for certain senior executives.
- Review the total number of shares issued to ensure alignment with the vesting tables provided in this filing.
- Check subsequent filings for the impact of these share issuances on the company's total share count and dilution.